4//SEC Filing
Lebovits Chaim 4
Accession 0001104659-24-105215
CIK 0001137883other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:00 AM ET
Size
8.5 KB
Accession
0001104659-24-105215
Insider Transaction Report
Form 4
Lebovits Chaim
President & CEO
Transactions
- Purchase
Common Stock
2024-10-01$3.43/sh+1,836$6,292→ 80,960 total - Purchase
Common Stock
2024-09-30$0.23/sh+22,000$5,016→ 1,186,865 total
Holdings
- 133,389(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.2258 to $0.2302, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
- [F2]Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.40 to $3.45, inclusive.
- [F4]Includes (i) 128,919 shares of Common Stock owned by ACCBT Corp. and (ii) 4,470 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001406302
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 8:00 AM ET
- Size
- 8.5 KB